Skip to main content
Skip to footer

The new age digital contract research organizations

Dr. Alejandra Guerchicoff

Industry Leader, TCS ADD Safety, TCS

Paul Ingram

Industry Leader, TCS ADD Supply Management, TCS

You have these already downloaded

We have sent you a copy of the report to your email again.

Contract Research Organizations (CROs) have evolved and grown to serve the life sciences industry, academia, and research & development organizations, the roots of which are deeply entrenched across diverse aspects of clinical trials.

In today’s data driven world, CROs must invest in digital technologies to improve collaboration across the clinical trial ecosystem and transform services, products, and processes to not only retain but also enhance their leadership over clinical trials conduct.

The ideal CRO digital platform offers an opportunity to un-burden bureaucracy put upon sites today and drive data capture and integrity straight into the digital eco-system allowing earlier intervention, if required, or more rapid conclusion of trials to support registration or go/no-go decisions.

Read this whitepaper to understand the parameters that drive digitalization for the CROs

Read More

About the authors

Dr. Alejandra Guerchicoff
Dr. Alejandra Guerchicoff is a PhD in molecular genetics with a post-doctoral training in molecular cardiology. She is working as an Industry Advisor for TCS ADD platform with the Life Sciences unit at Tata Consultancy Services (TCS). Dr. Guerchicoff possesses a rich experience of more than 20 years in the domain of clinical research and post-marketing pharmacovigilance, for medical devices, drugs, combination products, gene and cell therapy, and software as medical device products.
Read more about authorRead more about author Read more about author
Paul Ingram
During Dr. Ingram’s 25-year career, his work has focused on pharmaceutical research and development and medical devices. He has over 15 years of experience in clinical supplies, working in both Phase 1 unit manufacturing suites and trial supplies service companies, including Quintiles (later Aptuit), Fisher Clinical and Catalent.
Read more about authorRead more about author Read more about author

Related reading

Next-gen clinical trials on a digital platform

Customer Testimonial | 27 Jan 2023

Adopting a Design Thinking Approach for Risk-Based Monitoring

White Paper | 23 Dec 2022

Bayer overhauls its trial planning process

White Paper | 23 Dec 2022

Technology-Driven EDC Platform for Medical Device Trials

White Paper | 23 Dec 2022

Transformation starts here

Learn how we can help you bring drugs to the market faster.

Talk to our experts

Find out more